Weifeng Li

2.4k total citations
70 papers, 1.9k citations indexed

About

Weifeng Li is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Weifeng Li has authored 70 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 28 papers in Immunology and 17 papers in Pharmacology. Recurrent topics in Weifeng Li's work include Immune Response and Inflammation (14 papers), Berberine and alkaloids research (12 papers) and NF-κB Signaling Pathways (11 papers). Weifeng Li is often cited by papers focused on Immune Response and Inflammation (14 papers), Berberine and alkaloids research (12 papers) and NF-κB Signaling Pathways (11 papers). Weifeng Li collaborates with scholars based in China and Hong Kong. Weifeng Li's co-authors include Xiaofeng Niu, Ting Fan, Qingli Mu, Wenbing Zhi, Huimin Huang, Huan Yao, Jinmeng Zhao, Zehong He, Huani Li and Xiumei Wang and has published in prestigious journals such as Archives of Biochemistry and Biophysics, Journal of Ethnopharmacology and Experimental Cell Research.

In The Last Decade

Weifeng Li

67 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weifeng Li China 28 828 349 318 313 302 70 1.9k
Sherif T. S. Hassan Czechia 27 770 0.9× 296 0.8× 259 0.8× 301 1.0× 341 1.1× 51 2.1k
Hee‐Sung Chae South Korea 28 1.0k 1.2× 314 0.9× 206 0.6× 496 1.6× 271 0.9× 98 2.1k
Lian Zhou China 28 1.1k 1.3× 388 1.1× 359 1.1× 418 1.3× 329 1.1× 70 2.1k
Xiangchun Shen China 29 1.3k 1.5× 384 1.1× 253 0.8× 406 1.3× 329 1.1× 200 2.9k
Pallab Maity Germany 29 885 1.1× 309 0.9× 232 0.7× 244 0.8× 181 0.6× 48 2.6k
Chi Teng Vong Macao 25 1.0k 1.3× 306 0.9× 283 0.9× 195 0.6× 230 0.8× 55 2.2k
Xia Luo China 26 768 0.9× 325 0.9× 310 1.0× 427 1.4× 365 1.2× 59 1.8k
Yann‐Lii Leu Taiwan 35 1.0k 1.3× 372 1.1× 427 1.3× 472 1.5× 275 0.9× 90 2.8k
Chian‐Jiun Liou Taiwan 33 1.1k 1.3× 335 1.0× 351 1.1× 306 1.0× 231 0.8× 74 2.4k
Mee-Young Lee South Korea 27 796 1.0× 505 1.4× 223 0.7× 359 1.1× 241 0.8× 137 2.2k

Countries citing papers authored by Weifeng Li

Since Specialization
Citations

This map shows the geographic impact of Weifeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifeng Li more than expected).

Fields of papers citing papers by Weifeng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weifeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifeng Li. The network helps show where Weifeng Li may publish in the future.

Co-authorship network of co-authors of Weifeng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Weifeng Li. A scholar is included among the top collaborators of Weifeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weifeng Li. Weifeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Rongyan, Mingjuan Li, Weitao Li, et al.. (2025). Sustained Release of αO-Conotoxin GeXIVA[1,2] via Hydrogel Microneedle Patch for Chronic Neuropathic Pain Management. Marine Drugs. 23(4). 161–161.
2.
Yu, Jinjin, Lili Zhou, Xinyao Liu, et al.. (2024). Exploring molecular mechanism of Panlongqi Tablet (PLQT) against RA: Integrated network pharmacology, molecular docking and experiment validation. International Immunopharmacology. 144. 113639–113639.
3.
Wang, Siqi, et al.. (2024). Glycoprotein from selenium-enriched yam activates immune cells and enhances intestinal immunity via the NF-κB signaling pathway. Food Bioscience. 61. 104671–104671. 1 indexed citations
4.
Wang, Tao, Ping Li, Yongqiang Li, et al.. (2024). Exportin XPO6 upregulation activates the TLR2/MyD88/NF-κB signaling by facilitating TLR2 mRNA nuclear export in COPD pulmonary monocytes. International Immunopharmacology. 135. 112310–112310. 5 indexed citations
5.
Huang, Qiuxia, Xin Xiao, Jinjin Yu, et al.. (2022). Tectoridin exhibits anti-rheumatoid arthritis activity through the inhibition of the inflammatory response and the MAPK pathway in vivo and in vitro. Archives of Biochemistry and Biophysics. 727. 109328–109328. 14 indexed citations
6.
Li, Weifeng, Qiuxia Huang, Jinjin Yu, et al.. (2022). Schisandrin improves lipopolysaccharide‐induced acute lung injury by inhibiting the inflammatory response in vivo and in vitro. Journal of Food Biochemistry. 46(7). e14141–e14141. 4 indexed citations
7.
Yu, Jinjin, Weifeng Li, Lintao Zhao, et al.. (2021). Quyu Shengxin capsule (QSC) inhibits Ang-II-induced abnormal proliferation of VSMCs by down-regulating TGF-β, VEGF, mTOR and JAK-STAT pathways. Journal of Ethnopharmacology. 275. 114112–114112. 4 indexed citations
8.
Li, Wenqi, Jinjin Yu, Xin Xiao, et al.. (2020). Imperatorin reduces the inflammatory response of atherosclerosis by regulating MAPKs signaling pathway in vivo and in vitro. International Immunopharmacology. 90. 107170–107170. 10 indexed citations
9.
Niu, Xiaofeng, Lulu Zang, Wenqi Li, et al.. (2019). Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway. International Immunopharmacology. 81. 106024–106024. 38 indexed citations
10.
Li, Weifeng, Wenbing Zhi, Jinmeng Zhao, et al.. (2018). Cinnamaldehyde protects VSMCs against ox-LDL-induced proliferation and migration through S arrest and inhibition of p38, JNK/MAPKs and NF-κB. Vascular Pharmacology. 108. 57–66. 34 indexed citations
11.
Sun, Qing, Weifeng Li, Huani Li, et al.. (2017). Preparation, Characterization and Anti-Ulcer Efficacy of Sanguinarine Loaded Solid Lipid Nanoparticles. Pharmacology. 100(1-2). 14–24. 13 indexed citations
12.
Niu, Xiaofeng, Fang Liu, Weifeng Li, et al.. (2017). Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro. Inflammation. 40(4). 1111–1122. 29 indexed citations
13.
Li, Weifeng, Xiumei Wang, Xiaofeng Niu, et al.. (2016). Protective Effects of Nobiletin Against Endotoxic Shock in Mice Through Inhibiting TNF-α, IL-6, and HMGB1 and Regulating NF-κB Pathway. Inflammation. 39(2). 786–797. 29 indexed citations
14.
Niu, Xiaofeng, Yu Wang, Weifeng Li, et al.. (2015). Protective effects of Isofraxidin against lipopolysaccharide-induced acute lung injury in mice. International Immunopharmacology. 24(2). 432–439. 59 indexed citations
15.
Niu, Xiaofeng, Qingli Mu, Weifeng Li, et al.. (2014). Esculentic acid, a novel and selective COX-2 inhibitor with anti-inflammatory effect in vivo and in vitro. European Journal of Pharmacology. 740. 532–538. 27 indexed citations
16.
Niu, Xiaofeng, Qingli Mu, Weifeng Li, et al.. (2014). Protective effects of esculentic acid against endotoxic shock in Kunming mice. International Immunopharmacology. 23(1). 229–235. 7 indexed citations
17.
Li, Weifeng, Huan Yao, Xiaofeng Niu, et al.. (2014). Protective effect of δ-amyrone against ethanol-induced gastric ulcer in mice. Immunobiology. 220(6). 798–806. 23 indexed citations
18.
Niu, Xiaofeng, Hua Hu, Weifeng Li, et al.. (2014). Protective effect of total alkaloids on lipopolysaccharide-induced acute lung injury. Journal of Surgical Research. 189(1). 126–134. 10 indexed citations
19.
Niu, Xiaofeng, Ting Fan, Weifeng Li, Xing Wei, & Huimin Huang. (2012). The anti-inflammatory effects of sanguinarine and its modulation of inflammatory mediators from peritoneal macrophages. European Journal of Pharmacology. 689(1-3). 262–269. 108 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sherif T. S. Hassan Breakdown of academic impact, for papers by Hee‐Sung Chae Breakdown of academic impact, for papers by Lian Zhou Breakdown of academic impact, for papers by Xiangchun Shen Breakdown of academic impact, for papers by Pallab Maity Breakdown of academic impact, for papers by Chi Teng Vong Breakdown of academic impact, for papers by Xia Luo Breakdown of academic impact, for papers by Yann‐Lii Leu Breakdown of academic impact, for papers by Chian‐Jiun Liou Breakdown of academic impact, for papers by Mee-Young Lee
Rankless by CCL
2026